| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 16 | |
| #2 | United States | 13 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds | |
| #5 | Analysing materials | |
| #6 | Special acyclic compounds | |
| #7 | Microorganisms | |
| #8 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Demuth Hans-Ulrich | 29 |
| #2 | Heiser Ulrich | 12 |
| #3 | Hoffmann Torsten | 12 |
| #4 | Schilling Stephan | 10 |
| #5 | Hoffmann Matthias | 7 |
| #6 | Glund Konrad | 6 |
| #7 | Rahfeld Jens-Ulrich | 5 |
| #8 | Von Hoersten Stephan | 5 |
| #9 | Kleinschmidt Martin | 4 |
| #10 | Gans Kathrin | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2010125086A1 | Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions | |
| US2006194852A1 | Glutaminyl based DPIV inhibitors | |
| US2007293426A1 | Methods for improving islet signaling in diabetes mellitus and for its prevention | |
| WO2005039548A2 | Use of effectors of glutaminyl and glutamate cyclases | |
| WO2004099134A2 | Glutaminyl based dp iv-inhibitors | |
| WO03015768A2 | Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |